Fig. 11From: Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancerCorrelation of SRXN1 expression in patients with GSVA scores in response to oxidative stress in the TCGA PRAD datasetBack to article page